Recently accumulating evidence has revealed that NEK2 overexpression occurred in several neoplastic diseases - including hepatocellular carcinoma 5, colorectal cancer 6, lung cancer 7, prostate cancer 8, breast cancer 9, and glioma 10. This evidence concerns the gene NEK2 and hepatocellular carcinoma.